Coming to Terms with the FDA Commissioner

The Institute of Medicine thinks FDA needs more stability at the highest level, and thinks a six-year fixed term for the commissioner is a good solution. But FDA's new commissioner doesn't agree.

Fifteen months after starting the job, Andrew von Eschenbach finally has the title: the former director of the National Cancer Institute was confirmed by the Senate as the twentieth commissioner of the Food & Drug Administration on December 7. He was sworn in December 13.

The swearing-in was anti-climactic at best. Von Eschenbach took over as FDA commissioner in September 2005, stepping in to calm...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet